Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
 
Generic Name:  Dendritic cell/tumor cell fusion vaccine + recombinant human interleukin 12
Date Designated:  01/25/2017
Orphan Designation:  Treatment of malignant glioma
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
CyTIX Inc.
7F Terada Bldg, 2-3-3 Shibakoen
Minato-ku, Tokyo
Japan

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-